Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor for Metabolic and Virology Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a nanomolar-affinity competitive inhibitor of heme oxygenase (HO) enzymes, reproducibly inhibiting HO activity in vitro and in vivo (APExBIO). It displays a Ki of 14 nM and can reduce serum bilirubin in neonatal hyperbilirubinemia models. The compound is used extensively for dissecting heme catabolism, metabolic syndrome, insulin resistance, and metaflammation mechanisms (Koyaweda et al., 2026). No clinical trials are registered as of 2024, but its research applications are supported by robust animal and cell-based data. APExBIO supplies validated Tin Mesoporphyrin IX (chloride) (SKU C5606) with detailed protocols and technical support.

Biological Rationale

Heme oxygenase (HO) enzymes catalyze the oxidative degradation of heme, producing biliverdin, ferrous iron, and carbon monoxide. This process regulates redox homeostasis, cell signaling, and metabolic adaptation (Koyaweda et al., 2026). Dysregulated HO activity is implicated in liver disease, metabolic syndrome, viral infections (notably HBV), and insulin resistance. Inhibition of HO can block downstream pathways involved in reactive oxygen species (ROS) modulation and inflammatory signaling. Tin Mesoporphyrin IX (chloride) is designed to enable selective, competitive inhibition of HO, thereby serving as a precise tool to probe these pathways.

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) is a synthetic metalloporphyrin resembling the heme substrate. It competitively binds to the active site of HO-1 and HO-2 isoforms, displacing endogenous heme. The compound exhibits a Ki of 14 nM, reflecting strong, nanomolar affinity for HO enzymes (APExBIO). Upon binding, it blocks the conversion of heme to biliverdin, iron, and carbon monoxide, thereby inhibiting heme catabolism. In vivo, Tin Mesoporphyrin IX (chloride) administered at 1 pmol/kg body weight inhibits hepatic, renal, and splenic HO activity for extended periods. This leads to reduced bilirubin formation and altered heme saturation in metabolic enzymes such as tryptophan pyrrolase (Next-Generation Heme Oxygenase Inhibitors: Mechanistic Roadmap). This mode of action underpins its use in metabolic disease, liver function, and virology research.

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits HO activity with a Ki of 14 nM in purified enzyme assays (APExBIO).
• In animal models, a single dose of 1 pmol/kg body weight suppresses hepatic and renal HO activity for at least 24 hours (Reliable Heme Oxygenase Research Tools).
• Reduces serum bilirubin in neonatal hyperbilirubinemia models, demonstrating translational relevance for metabolic and pediatric research (APExBIO).
• ICAA-dependent antiviral activity against HBV is mechanistically linked to HO-1 modulation, supporting the use of HO inhibitors as mechanistic probes (Koyaweda et al., 2026).
• Demonstrates solubility up to 0.5 mg/ml in DMSO and 1 mg/ml in DMF; recommended storage at -20°C for optimal stability (product documentation: APExBIO).

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is a cornerstone for:

• Heme oxygenase activity assays and kinetic studies.
• Research on metabolic disease, including insulin resistance and obesity-related metaflammation (Next-Generation Heme Oxygenase Inhibitors).
• Mechanistic studies in viral pathogenesis, especially hepatitis B virus (HBV) where HO-1 modulation affects viral replication (Koyaweda et al., 2026).
• Cellular and in vivo metabolic pathway dissection.

This article clarifies and extends previous coverage on Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor by providing explicit quantitative benchmarks, workflow integration steps, and updated evidence from virology studies.

Common Pitfalls or Misconceptions

• Tin Mesoporphyrin IX (chloride) is not approved for human clinical use; all studies are preclinical or in vitro.
• Its inhibitory activity is specific to heme oxygenase and does not broadly block other heme-containing enzymes without off-target effects being evaluated.
• Stability and solubility are limited in aqueous buffers; DMSO or DMF are recommended solvents for stock solutions.
• Extended storage of solutions at temperatures above -20°C results in compound degradation.
• Does not serve as a direct antiviral agent; its effect in viral models is via host pathway modulation.

Workflow Integration & Parameters

For optimal heme oxygenase inhibition assays, Tin Mesoporphyrin IX (chloride) should be dissolved in DMSO (up to 0.5 mg/ml) or DMF (up to 1 mg/ml). Solutions should be aliquoted and stored at -20°C, with use restricted to short-term applications. Standard protocols employ concentrations around 0.1–1 μM for cell-based assays or as indicated by kinetic requirements. Pre-incubation with enzyme or cell lysate is recommended for 15–30 min at 37°C. For in vivo models, dosing at 1 pmol/kg is validated for hepatic, renal, and splenic HO inhibition (Reliable Heme Oxygenase Research Tools). Workflow diagrams and troubleshooting protocols are available from APExBIO’s technical resources. For laboratory challenges relating to reproducibility or off-target controls, see Solving Lab Challenges with Tin Mesoporphyrin IX (chloride), which this article updates with new mechanistic data and application boundaries.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) (SKU C5606; APExBIO) is a validated, potent tool for dissecting heme oxygenase signaling and metabolism. Its nanomolar inhibition profile, robust in vivo activity, and quantitative workflow support position it as the benchmark for metabolic disease and virology research. Ongoing studies will clarify its full translational potential, but its role in preclinical pathway analysis is well-established. For product details, protocols, and technical data, refer to the APExBIO Tin Mesoporphyrin IX (chloride) product page.